Publication:
Effectiveness of a healthy lifestyle promotion program as adjunctive teletherapy for treatment-resistant major depression during COVID 19 pandemic A randomized clinical trial protocol

dc.contributor.authorNavarro, Capilla
dc.contributor.authorYáñez, Aina M
dc.contributor.authorGarcia, Aurora
dc.contributor.authorSeguí, Andrea
dc.contributor.authorGazquez, Francisco
dc.contributor.authorMarino, Jose Antonio
dc.contributor.authorIbarra, Olga
dc.contributor.authorSerrano-Ripoll, Maria Jesus
dc.contributor.authorGomez-Juanes, Rocío
dc.contributor.authorBennasar-Veny, Miquel
dc.contributor.authorSalva, Joan
dc.contributor.authorOlivan, Barbara
dc.contributor.authorRoca, Miquel
dc.contributor.authorGili, Margalida
dc.contributor.authorGarcia Toro, Mauro
dc.date.accessioned2024-09-13T09:13:35Z
dc.date.available2024-09-13T09:13:35Z
dc.date.issued2020-11-06
dc.description.abstractIntroduction: Treatment-resistant depression (TRD) has a high prevalence and can be exacerbated by poor physical health and economic hardships, which have become common stressors during the current COVID-19 pandemic. The therapeutic approaches used to treat these patients are not always available, may be not be accepted by some patients, and often require face-to-face interactions. Objective: The main aim of this study will be to evaluate the effectiveness of an Internet-based adjuvant lifestyle-based intervention for patients with TRD. Methods: This will be a parallel, randomized, and controlled clinical trial. A total of 180 patients with TRD will be randomly allocated (1:1:1) to 1 of 3 groups: treatment prescribed by the mental health team and written suggestions for lifestyle changes (placebo control group); treatment prescribed by the mental health team, written suggestions for lifestyle changes, and an 8-week mindfulness-based cognitive therapy program (active control group); or treatment prescribed by the mental health team, written suggestions for lifestyle changes, and an 8-week lifestyle change promotion program (intervention group). We will perform this study during the COVID-19 pandemic, and will administer interventions by teletherapy, and contact participants by telephone calls, text messages, and/or teleconferences. We will collect patient data using questionnaires administered at baseline, immediately after the intervention, and after 6 and 12 months. The primary outcome will be score on the Beck Depression Inventory-II. The secondary outcomes will be score on the Clinical Global Impressions Scale (used to quantify and track patient progress and treatment response over time) and health-related quality of life measured using the European Quality of Life-5 Dimensions Questionnaire. Discussion: Patients with TRD are especially vulnerable when face-to-face psychotherapy is unavailable. The main strength of the proposed study is the novelty of the intervention to be used as an adjuvant therapy. Our results may provide guidance for treatment of patients with TRD in future situations that require lockdown measures.en
dc.description.sponsorshipThis work was supported by the Spanish Ministry of Science, Innovation and Universities grant number RTI2018-093590-B-I00, following a rigorous peer-reviewed funding process. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.es_ES
dc.format.number45es_ES
dc.format.volume99es_ES
dc.identifier.citationNavarro C, Yañez AM, Garcia A, Segui A, Gazquez F, Marino JA, et al. Effectiveness of a healthy lifestyle promotion program as adjunctive teletherapy for treatment-resistant major depression during COVID 19 pandemic A randomized clinical trial protocol. Medicine (Baltimore). 2020 Nov 06;99(45).en
dc.identifier.doi10.1097/MD.0000000000022958
dc.identifier.e-issn1536-5964es_ES
dc.identifier.issn0025-7974
dc.identifier.journalMedicinees_ES
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/16552
dc.identifier.pubmedID33157937es_ES
dc.identifier.puiL633368617
dc.identifier.scopus2-s2.0-85095801161
dc.identifier.urihttps://hdl.handle.net/20.500.12105/22933
dc.identifier.wos588168200031
dc.language.isoengen
dc.publisherLippincott Williams & Wilkins (LWW)
dc.relation.publisherversionhttps://dx.doi.org/10.1097/MD.0000000000022958en
dc.rights.accessRightsopen accessen
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19
dc.subjectMindfulness-based cognitive therapy
dc.subjectMulticomponent lifestyle program
dc.subjectTreatment-resistant depression
dc.subject.decsEnsayos Clínicos Pragmáticos como Asunto*
dc.subject.decsTelemedicina*
dc.subject.decsPromoción de la Salud*
dc.subject.decsAtención Plena*
dc.subject.decsCOVID-19*
dc.subject.decsTerapia Cognitivo-Conductual*
dc.subject.decsTrastorno Depresivo Resistente al Tratamiento*
dc.subject.decsHumanos*
dc.subject.decsCalidad de Vida*
dc.subject.decsEstilo de Vida Saludable*
dc.subject.decsEncuestas y Cuestionarios*
dc.subject.decsNeumonía Viral*
dc.subject.decsInfecciones por Coronavirus*
dc.subject.decsPandemias*
dc.subject.meshCoronavirus Infections*
dc.subject.meshPragmatic Clinical Trials as Topic*
dc.subject.meshHumans*
dc.subject.meshMindfulness*
dc.subject.meshPandemics*
dc.subject.meshDepressive Disorder, Treatment-Resistant*
dc.subject.meshQuality of Life*
dc.subject.meshCognitive Behavioral Therapy*
dc.subject.meshHealth Promotion*
dc.subject.meshHealthy Lifestyle*
dc.subject.meshTelemedicine*
dc.subject.meshCOVID-19*
dc.titleEffectiveness of a healthy lifestyle promotion program as adjunctive teletherapy for treatment-resistant major depression during COVID 19 pandemic A randomized clinical trial protocolen
dc.typeresearch articleen
dspace.entity.typePublication
relation.isPublisherOfPublicationf94ef1f2-f26f-4ebc-84d7-bb83b401e22a
relation.isPublisherOfPublication.latestForDiscoveryf94ef1f2-f26f-4ebc-84d7-bb83b401e22a

Files